I find us in a great position now! We will become
Post# of 148187
(Total Views: 449)
Posted On: 08/27/2022 5:26:05 PM
Re: Evil Rabbit #128089
I find us in a great position now! We will become part of BP and get Leronlimab out, of this I have no doubt.
Not all of the FDA is part of BP and we could be helped in LH later??
There are few areas I think the FDA needs to answer for: Remdesivir is still, after over a million deaths in USA alone, the number one therapeutic for Covid even though it doesn't work. Second, it takes 28 days prove a therapeutics worth in Covid so after "anecdotal claims" why did it take the FDA over a full year to figure out nothing about Leronlimab? Why after our success in Long Haulers did they not fast track Leronlimab for LH? The FDA and NIH has had over 2 years of opportunity to help get leronlimab out there for Covid, but NO, they put up road blocks at every turn. Pfizer says they have a new pill and boom, "We are good" with Pfizer immediately, so not an even playing field.
No question Amarex failed us or worse. Just watch how fast this all moves once we join the stupid BP game!
Not all of the FDA is part of BP and we could be helped in LH later??
There are few areas I think the FDA needs to answer for: Remdesivir is still, after over a million deaths in USA alone, the number one therapeutic for Covid even though it doesn't work. Second, it takes 28 days prove a therapeutics worth in Covid so after "anecdotal claims" why did it take the FDA over a full year to figure out nothing about Leronlimab? Why after our success in Long Haulers did they not fast track Leronlimab for LH? The FDA and NIH has had over 2 years of opportunity to help get leronlimab out there for Covid, but NO, they put up road blocks at every turn. Pfizer says they have a new pill and boom, "We are good" with Pfizer immediately, so not an even playing field.
No question Amarex failed us or worse. Just watch how fast this all moves once we join the stupid BP game!
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼